← Back to screener

Evolus, Inc. EOLS

Rank #2485 · Nasdaq · $0.5B market cap
Audited by Ernst & Young LLP, no going-concern flag in the latest filing.
Score
14.4
P/E
-7.8
P/B
26.17
ROE
-333.5%
Op. Margin
-24.4%
Debt Ratio
1227%

Health Check — percentile rank within this universe, based on the latest annual filing

Valuation ★☆☆☆☆
Poor

P/E -7.8x, P/B 26.17x. Ranks in the top 88% of the universe.

Profitability ★☆☆☆☆
Poor

ROE -333.5%. Ranks in the top 90% of the universe.

Safety ★☆☆☆☆
Poor

Debt ratio 1227%. Ranks in the top 94% of the universe. Above 200% signals meaningful leverage risk.

Growth ★★★★☆
Excellent

Revenue growth of 36.0% year over year. Ranks in the top 10% of the universe.

Growth is the relative strength · Valuation is the relative weakness (relative to this universe).

Financials annual, from SEC 10-K filings

FYRevenueOp. IncomeNet IncomeEquityOp. Margin%Debt%
2018–$-0.0B$-0.0B$-0.0B–-3205
2019$0.0B$-0.0B$-0.0B$0.1B–104
2020$0.0B$-0.1B$-0.1B$0.1B-283.3191
2021$0.1B$-0.2B$-0.2B$0.1B-270.7355
2022$0.1B$-0.0B$-0.0B$-0.1B-44.6-241
2023$0.1B$-0.1B$-0.1B$0.1B-44.0195
2024$0.1B$-0.1B$-0.1B$0.1B-44.0256
2025$0.2B$-0.0B$-0.1B$0.0B-24.41227

← See the full screener